Skip to content

Mindfulness to Enhance Quality of Life and Support Advance Care Planning

Mindfulness to Enhance Quality of Life and Support Advance Care Planning (MEANING): A Randomized Controlled Pilot Trial for Adults With Metastatic Cancer and Their Family Caregivers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03257007
Acronym
MEANING
Enrollment
108
Registered
2017-08-22
Start date
2017-05-09
Completion date
2017-12-11
Last updated
2020-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advance Care Planning, Family Caregiver, Meditation, Metastatic Cancer, Mindfulness, Palliative Care, Quality of Life, Supportive Care

Brief summary

The MEANING trial is a randomized controlled mixed methods pilot designed to compare a novel mindfulness meditation-based intervention (MEANING) to usual care for adults with advanced-stage solid malignancies and their family caregivers.

Detailed description

Mindfulness meditation practices have reduced emotional distress, avoidant coping, and improved spiritual well-being in adult cancer patients. These beneficial effects may occur through present-moment acceptance of unpleasant thoughts, feelings, and circumstances and adaptive coping through self-awareness, self-regulation, and self-transcendence. Most mindfulness trials in cancer have focused on early-stage survivors; however, preliminary evidence suggests that mindfulness may help reduce distress in patients with advanced cancer and their family caregivers (FCGs). Sixty patients with an advanced-stage solid malignancy and their FCGs (60 dyads) will be randomized in equal numbers to receive either the 6-week mindfulness intervention or usual care. Both groups will receive standard cancer care throughout the study period. Dyads randomized to the mindfulness arm will learn mindfulness meditation practices (e.g., body scan, sitting meditation) and mindful communication practices to enhance quality of life, support advance care planning engagement, and improve a variety of secondary outcomes. The study will use a mixed methods 2-arm randomized design to examine the effects of the mindfulness intervention compared to usual care and seek to explain trial results using insights gleaned from post-intervention qualitative interviews.

Interventions

BEHAVIORALMindfulness

The Mindfulness intervention sessions are designed to cultivate present-moment awareness in everyday life to facilitate adaptive and non-reactive relating to thoughts, feelings, and bodily sensations. Participants will be provided with 10-20 minute audio recordings of each of 5 mindfulness practices covered in class, recorded in the facilitator's voice. Participants will be encouraged to practice mindfulness at home 10-20 minutes per day, 6 days per week. Participants will be provided with weekly diaries on which to record type and amount of home practice of mindfulness skills.

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

Participants are blind to study hypotheses.

Intervention model description

Participants will be assigned in equal numbers using block randomization to the mindfulness intervention or usual care. The course curriculum for the mindfulness intervention is modeled on the Mindfulness-Based Stress Reduction program which involves intensive experiential training of participants in secular mindfulness meditation practices (i.e., body scan, sitting meditation, gentle hatha yoga with chair adaptations, compassion meditation), with an emphasis on embodying interpersonal mindfulness in dialogue.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

-Patients * Patient is at least 18 years of age. * Patient is at least 3 weeks post-diagnosis of an incurable (locally advanced or metastatic) solid malignancy. * Patient's attending medical oncologist would not be surprised if the patient died in the next 12 months. * Patient has not completed a POST form. * Patient scores ≥ 7 on the Mini-Mental Adjustment to Cancer cognitive avoidance subscale. * Patient is willing and able to consent and travel to the class location for 6 weekly 2-hour sessions. * Patient has a family member or close friend eligible and interested in participating in the study. * Patient has adequate English fluency for completion of data collection Inclusion Criteria-Family Care Givers (FCG) * FCG is at least 18 years of age. * FCG has been invited to participate in the trial with a patient who meets eligibility criteria above. * FCG is willing and able to consent and travel to the class location for 6 weekly 2-hour sessions. * FCG has adequate English fluency for completion of data collection

Exclusion criteria

-Patients * Patient reports a score of \> 2 on the Activities and Function item from the Patient Generated Subjective Global Assessment91 (PG-SGA; the patient-reported version of the Eastern Cooperative Oncology Group score). * Patient makes 3 or more errors on a validated 6-item cognitive screener or exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation. * Currently receiving hospice care (patients who enroll in hospice during the trial will have the option of continuing trial participation).

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in quality of life (QoL) for PatientsBaseline, 6 weeks, and 10 weeksQoL for patients will be assessed with the McGill Quality of Life Inventory.
Change from baseline in quality of life (QoL) for Family CaregiversBaseline, 6 weeks, and 10 weeksQoL for family caregivers will be assessed with the Caregiver Quality of Life - Cancer scale (CQoLC).

Secondary

MeasureTime frameDescription
Change from baseline in caregiver burdenBaseline, 6 weeks, and 10 weeksCaregiver burden will be measured using the Zarit Burden Interview (family caregiver measure only)
Change from baseline in avoidant copingBaseline, 6 weeks, and 10 weeksAvoidant coping will be assessed using the Mini-MAC Cognitive Avoidance subscale
Change from baseline in depressive symptomsBaseline, 6 weeks, and 10 weeksDepressive symptoms will be assessed using the PHQ-8
Change from baseline in anxietyBaseline, 6 weeks, and 10 weeksAnxiety will be assessed using the GAD-7
Change from baseline in spiritual well-beingBaseline, 6 weeks, and 10 weeksSpiritual well-being will be measured using the FACIT-SP.
Change from baseline in sleep disturbanceBaseline, 6 weeks, and 10 weeksSleep disturbance will be assessed using the PROMIS Sleep Disturbance.
Change from baseline in advance care planning (ACP) stage of changeBaseline, 6 weeks, and 10 weeksACP stage of change will be assessed by a measure modified from Fried et. al assessing stage of change for 3 advance care planning behaviors (completing a living will, medical power of attorney form, or POLST form; patient only measure).
Change from baseline in interpersonal closenessBaseline, 6 weeks, and 10 weeksInterpersonal closeness will be assessed using the Perceived Interpersonal Closeness Scale.
Change from baseline in acceptance of illnessBaseline, 6 weeks, and 10 weeksAcceptance of illness will be assessed using the PEACE Scale.
Change from baseline in mindfulnessBaseline, 6 weeks, and 10 weeksMindfulness will be assessed using the FFMQ-SF Non-reactivity to Internal Experience and Acting with Awareness subscales.
Distress ThermometerBaseline, 6 weeks, and 10 weeksDistress will be assessed using the Distress Thermometer.
Intervention satisfaction and helpfulness6 weeksSatisfaction and helpfulness with the Mindfulness intervention will be assessed using single-item investigator-created 7- and 10-point Likert scales, respectively (Mindfulness group only).
Change from baseline in family communicationBaseline, 6 weeks, and 10 weeksFamily communication will be assessed using the Social Constraint Scale
Change from baseline in advance care planning (ACP) engagementBaseline, 6 weeks, and 10 weeksACP engagement (self-efficacy, readiness) will be measured using 2 subscales of the Advance Care Planning Engagement Survey (patient only measure).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026